Anzeige
Mehr »
Donnerstag, 28.08.2025 - Börsentäglich über 12.000 News
Patentschutz bis in die 2040er - Biotech-Geheimtipp vor möglichem Fast-Track-Durchbruch in den USA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W1KK | ISIN: US23282W6057 | Ticker-Symbol: KK3A
Tradegate
27.08.25 | 21:48
32,600 Euro
0,00 % 0,000
1-Jahres-Chart
CYTOKINETICS INC Chart 1 Jahr
5-Tage-Chart
CYTOKINETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
32,20032,80007:53
32,20032,80007:33

Aktuelle News zur CYTOKINETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoCytokinetics, Incorporated: Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 20252
CYTOKINETICS Aktie jetzt für 0€ handeln
20.08.CYTOKINETICS INC - 8-K, Current Report2
20.08.Cytokinetics appoints James Daly to board of directors1
20.08.Cytokinetics, Incorporated: Cytokinetics Names Jim Daly to Board of Directors2
19.08.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)87SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of...
► Artikel lesen
08.08.Cytokinetics targets early Q1 2026 U.S. aficamten launch as FDA review advances and clinical milestones approach12
08.08.Cytokinetics-Aktie legt nach starken Q2-Zahlen zu11
07.08.CYTOKINETICS INC - 10-Q, Quarterly Report2
07.08.Cytokinetics GAAP EPS of -$1.12 beats by $0.25, revenue of $66.76M beats by $64.69M4
07.08.CYTOKINETICS INC - 8-K, Current Report1
29.07.Raymond James downgrades Cytokinetics stock rating to Market Perform7
29.07.Raymond James stuft Cytokinetics auf "Market Perform" herab3
24.07.Cytokinetics, Incorporated: Cytokinetics to Announce Second Quarter Results On August 7, 20251
18.07.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)153SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an aggregate of...
► Artikel lesen
10.07.Cytokinetics, Incorporated: Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 202511
06.07.Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT6
17.06.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)209SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2025 it granted stock options to purchase an aggregate of...
► Artikel lesen
12.06.Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan4
10.06.Cytokinetics Calls for Donations4
10.06.Cytokinetics, Incorporated: Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program2
Weiter >>
94 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1